Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 23.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
23.02.24Norva24 Group AB: Revenue and profit growth continues183Year-end January-December 2023 October-December 2023Total operating revenue amounted to NOK 855.7 million (719.5), an increase of 18.9%. Currency adjusted organic growth was 5.2%.Revenue from customer...
► Artikel lesen
23.02.24Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2023140Summary of the interim report (relates to the Group) Full year (01/01/2023-12/31/2023) Net sales totaled SEK 8,273,000 (SEK 6,268,000). Operating profit/loss totaled SEK -65,933,000 (SEK...
► Artikel lesen
23.02.24Cyber Security 1 AB: CYBER1 Q4 REPORT 2023: CYBER1 concludes 2023 with a strong fourth quarter135Stockholm, Sweden- 23rd February 2024 - Cyber Security 1 AB (publ) ("The Company") ("CYBER1") (Nasdaq First North: CYB1) has released its Q4 2023 report, detailing a quarterly revenue growth of 16%...
► Artikel lesen
23.02.24ZignSec AB: Year-end Report 2023193With interim report for the period 1 October 2023 to 31 December 2023 Full year 2023 in summaryNet revenue amounted to SEK 84.7 (89.9) million, a decrease of 6% compared with the corresponding period...
► Artikel lesen
23.02.24FM Mattsson Mora Group AB: Year end report January-December 2023139October-December 2023Net sales were 449.6 MSEK (459.9), a decrease of 2.2% compared to the equivalent quarter in 2023. Organic growth was -4.4%.EBITA was 23.1 MSEK (46.6), an EBITA margin of 5.1% (10.1)....
► Artikel lesen
23.02.24Seafire AB: Seafire year-end report 2023: Weak margin, but strong cash flow towards the year-end152Revenue increased by 8% to SEK 227 million (210), while operating profit, adjusted EBITA, amounted to SEK 3 million (9) in Q4. A disappointing end to the year, primarily as a result of negative organic...
► Artikel lesen
23.02.24Lundin Gold Inc.: Lundin Gold Reports Fourth Quarter and Full Year Results68Production and Cost Performance Meets Upgraded Guidance VANCOUVER, BC, Feb. 22, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased...
► Artikel lesen
23.02.24Abliva AB: Abliva AB Year-End Report January - December 202321140 Patients Enrolled in Wave 1 of the FALCON Study | Fast Track Designation for KL1333 | Orphan Drug Designation for NV354 in both US and Europe 2023 SummaryImportant events during 2023KL1333The first...
► Artikel lesen
23.02.24SynAct Pharma AB: SynAct Pharma today publishes the fourth quarter and annual results of 2023196"We have excellent opportunities before us, and we remain focused on delivering patient, company and shareholder value," said Torbjørn Bjerke, CEO. October - December 2023The Group's net sales amounted...
► Artikel lesen
23.02.24Kancera AB: Interim Report Fourth Quarter 2023, October 1 - December 31288The period in brief - financial summary for the fourth quarterNet sales amounted to SEK 0 million (SEK 0).R&D expenses amounted to SEK 17,1 million (SEK 11,6 million).Operating income amounted to SEK...
► Artikel lesen
23.02.24Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer255PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its previously announced tender offer (the "Offer") to acquire all of the outstanding shares of RayzeBio...
► Artikel lesen
23.02.24Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio249PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc.® ("Mirati"). With the completion...
► Artikel lesen
23.02.24Sprott Junior Uranium Miners UCITS ETF: Neuer Themen-ETF von HANetf auf Xetra: Zugang zu kleinen und mittleren Unternehmen aus dem Bereich des Uranbergbaus363Seit Freitag ist der Exchange Traded Fund von HANetf in Kooperation mit Sprott Asset Management auf Xetra und Börse Frankfurt handelbar. Mit dem Sprott Junior Uranium Miners UCITS ETF bekommen Anleger*innen...
► Artikel lesen
23.02.24Edoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business Combination428Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting")...
► Artikel lesen
23.02.24Coherus BioSciences, Inc.: Coherus BioSciences Announces New Employment Inducement Grants581REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that effective February 20, 2024, the compensation committee...
► Artikel lesen
23.02.24Adamas One Corp.: Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)481SCOTTSDALE, Ariz., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) ("Adamas One," "Adamas" or the "Company"), The Original Lab-Grown Diamond Company, a high-tech company that leverages...
► Artikel lesen
23.02.24NeuroOne Medical Technologies Corp: NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)461EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical...
► Artikel lesen
23.02.24MoneyHero Limited: MoneyHero Group Appoints Rohith Murthy Chief Executive Officer476SINGAPORE, Feb. 23, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) ("MoneyHero" or the "Company"), a market-leading personal finance aggregation and comparison platform in Greater Southeast...
► Artikel lesen
23.02.24Celularity, Inc.: Celularity Announces 1-for-10 Reverse Stock Split475FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) ("Celularity"), a biotechnology company developing allogeneic cell therapies and advanced biomaterial products...
► Artikel lesen
23.02.24Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)279NOVATO, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
► Artikel lesen
Seite:  Weiter >>